Compare NNDM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNDM | SOPH |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.4M | 374.1M |
| IPO Year | 2015 | 2021 |
| Metric | NNDM | SOPH |
|---|---|---|
| Price | $1.50 | $4.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 2.3M | 90.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,437,000.00 | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 77.30 | N/A |
| 52 Week Low | $1.31 | $2.59 |
| 52 Week High | $2.32 | $5.70 |
| Indicator | NNDM | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 35.08 | 40.31 |
| Support Level | $1.47 | $3.86 |
| Resistance Level | $1.87 | $4.86 |
| Average True Range (ATR) | 0.10 | 0.35 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 2.15 | 8.79 |
Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.